The Food and Drug Administration today issued a final order exempting manufacturers from FDA premarket notification requirements for certain N95 respirators, disposable devices used to protect patients and health care providers from infection. Under a new memorandum of understanding between the FDA and National Institute for Occupational Safety and Health, organizations seeking to market N95 respirators that do not exceed certain criteria need only NIOSH certification. The final order and MOU, effective tomorrow, are intended to streamline regulatory requirements to help ensure adequate supply of the devices during public health emergencies.

Related News Articles

Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Headline
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness…
Headline
The Centers for Medicare & Medicaid Services July 10 announced it will provide resources and flexibilities to health care providers and residents who…
Headline
The Government Accountability Office yesterday released a report calling for the Department of Health and Human Services to improve its efforts responding to…
Headline
The Centers for Disease Control and Prevention March 4 announced it sent agency experts to Texas to assist local officials in responding to the state’s measles…
Headline
A school-aged child in Texas is the first reported individual to die from measles amid an outbreak in the South Plains and Panhandle regions of the state, the…